Life Sciences Times

Revvity Raises 2026 Outlook After Second-Quarter Earnings Increase

BostonGene Wins Three Honors in 2026 Artificial Intelligence Excellence Awards

Stoke Therapeutics Completes Enrollment in Phase 3 Dravet Syndrome Study

InfuSystem Reports $3.2 Million Profit as Second-Quarter Revenue Rises

CREATE Medicines Cleared to Begin Phase 1/2 Trial of In Vivo CAR-T Therapy for Autoimmune Diseases

Insilico Medicine Launches AI Benchmark for Drug Discovery Models

Apnimed Prices Upsized IPO at $16 Per Share, Raising $192 Million

Decoy Therapeutics Expands Patent Portfolio for Antiviral Platform

Adagio Medical Treats First Patient with Next-Generation Ventricular Tachycardia Ablation System

Biocon Launches Eylea Biosimilar Yesafili in the United States